Swab from tongue patch was sterile. KOH mount from tongue scrapings did not reveal fungal elements. Fungal culture was negative. Biopsy of the lesion could not be done as the patient did not give consent for it.
Diagnosis of black hairy tongue (BHT) was made. Olanzapine was discontinued. Follow-up was done every week for 1 month. Black coating on the tongue decreased at the first follow-up (1 st week). It disappeared completely at the second follow-up (2 nd week) and remained so at the third and fourth follow-ups.
On Naranjo adverse drug reaction (ADR) probability scale, the score was five, which revealed a probable ADR. The ADR has been reported to the Pharmacovigilance Programme of India, with worldwide unique number IN IPC 201646573.
The exact mechanism of BHT induced by olanzapine is not known. It has been suggested that anticholinergic property of olanzapine has potential to induce BHT. [1, 2] To the best of our knowledge, there are only two published reports of BHT related to olanzapine. In one case, it was prescribed in combination with lithium [3] and in other with fluoxetine. [4] We report this case to highlight the occurrence of BHT as a rare ADR of olanzapine and to sensitize clinicians about it.
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Conflicts of interest
Dermatological examination showed multiple coin-shaped hyperpigmented, well-demarcated patches varying in diameter from 1.5 cm to 6 cm over upper back, trunk, Sir, Fixed drug eruptions (FDEs) are uncommon cutaneous side effects of various drugs. Antidepressants are lesser known causative agents and selective serotonin reuptake inhibitors (SSRI) are considered even safer; however, we hereby report the first case of paroxetine-induced FDE.
A 40-year-old male patient presented with sudden onset, multiple hyperpigmented patches over upper back, trunk, abdomen, dorsum of hand, and posterior aspect of both thighs abdomen, dorsum of hand, and posterior aspect of both thighs. The lesions were mildly scaly and pruritic. Nail, hair, and mucosal examination showed no abnormality. The patient party refused skin biopsy considering the mental state of the patient.
According to the modified Hartwig and Siegel's adverse drug reaction severity assessment scale, [1] the reaction due to paroxetine was labeled as "mild" (level 2). Naranjo scale [2] and WHO Uppsala Monitoring Center scale [3] gave a score of 8 which suggests the reaction as "probable adverse effect."
Thus, a diagnosis of paroxetine-induced fixed drug reaction was done based on the history and clinical examination. Paroxetine was stopped, and the patient was referred to the psychiatrist to start another antidepressant. He was given betamethasone cream to be applied twice daily for 3 weeks. On follow-up, only some residual hyperpigmentation was seen for which 4% hydroquinone was given. The case was "preventable" according to the Preventability criteria given by Schumock and Thornton [4] scale as there was reliable history of a previous similar reaction to the same offending drug.
Paroxetine is an SSRI used for obsessive-compulsive disorder, major depression, panic disorders, generalized anxiety disorders, and social phobia. Akpinar and Dervis conducted an 8-year study wherein they found one case of paroxetine-induced urticaria and angioedema. [5] This report should make us aware of this rare adverse effect of paroxetine, which might be an anxiolytic and antidepressant for the patient but can become a cause for anxiety to the prescriber if not dealt with early.
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There are no conflicts of interest. Pretesting and cognitive interviewing are integral parts in translation of survey instrument was inadequate, or it was not described in detail. Hence, we intend to share this correspondence with journal readers. 1. The survey instrument used in the study was originally developed in English. It was translated into local languages and adapted for the study. However, the languages to which instrument was translated were not mentioned. It was necessary because Kolkata and Chennai have a mixed culture with population of different language speakers. [2, 3] Detailed linguistic Sir,
We read an article contributed by Zieger et al., published in 58 th issue of your journal. [1] In the study, authors assessed perception of stigma about mental illness in population of two Indian cities -Kolkata and Chennai and compared the level of stigma among population of these cities. The overall message conveyed through the result of the study is understandable. However, from our viewpoint, the adaptation of translated survey instrument
